Evidence map›Paper›PMID 35950860›Full record

ArticleMicrobiology spectrum2022

Boosting Cosmeceutical Peptides: Coupling Imidazolium-Based Ionic Liquids to Pentapeptide-4 Originates New Leads with Antimicrobial and Collagenesis-Inducing Activities.

Ana Gomes, Lucinda J Bessa, Iva Fernandes, Luísa Aguiar, Ricardo Ferraz, Cláudia Monteiro, M Cristina L Martins, Nuno Mateus, Paula Gameiro, Cátia Teixeira and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ana GomesLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Lucinda J BessaLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Iva FernandesLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Luísa AguiarLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Ricardo FerrazLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Cláudia Monteiroi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
M Cristina L Martinsi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.
Nuno MateusLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Paula GameiroLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Cátia TeixeiraLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.
Paula GomesLAQV-REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.ORCID 0000-0002-6018-4724
Universidade do Porto · PTInstitute of Mechanical Engineering and Industrial Mangement · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following our previous reports on dual-action antibacterial and collagenesis-inducing hybrid peptide constructs based on "pentapeptide-4" (PP4, with amino acid sequence KTTKS), whose

Indexed as

Anti-Infective AgentsCosmeceuticalsIonic LiquidsAnti-Bacterial AgentsCollagenGram-Negative BacteriaGram-Positive BacteriaHumansMicrobial Sensitivity TestsPeptidesAnti-Bacterial AgentsAnti-Infective AgentsCollagenCosmeceuticalsIonic LiquidsPeptidesantibacterialantifungalantimicrobial activitycollagen boostingcollagenesis-inductioncosmeceutical peptidesionic liquidMatrixylpentapeptide-4

Identifiers

PMID35950860
PMCPMC9431032
OpenAlexW4290804151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.